Seeking Alpha

PTLA
  Portola Pharmaceuticals - NASDAQ

11/24/2014, 4:45 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
PTLA vs. ETF Alternatives
Company Description
Portola Pharmaceuticals Inc is a biopharmaceutical company that develops & commercializes novel therapeutics in the areas of thrombosis, other hematologic disorders & inflammation for patients who currently have limited or no approved treatment options.